je.st
news
Home
› Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy
Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy
2013-01-02 02:28:49| drugdiscoveryonline News Articles
Insero Health, Inc., a company developing natural compounds to address unmet medical needs in neurological disorders, today announced that it has completed a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy
Tags: with
health
trial
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||